<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03039426</url>
  </required_header>
  <id_info>
    <org_study_id>RJBUPI</org_study_id>
    <nct_id>NCT03039426</nct_id>
  </id_info>
  <brief_title>Postoperative Cesarean Delivery Pain Relief; Diclofenac Versus Bupivacaine</brief_title>
  <official_title>A Randomized Comparison of Bupivacaine Peritoneal and Subcutaneous Infiltration Versus Diclofenac Intramuscular Injection for Postoperative Pain Relief in Patient Undergoing Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rajavithi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rajavithi Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled trial, compared postoperative pain score in patient undergoing&#xD;
      cesarean delivery between bupivacaine peritoneal and subcutaneous infiltration and diclofenac&#xD;
      intramuscular injection&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative cesarean delivery was painful that can effect daily activity, resulted in poor&#xD;
      quality of life and required morphine injection to relief pain which had both maternal and&#xD;
      breastfeeding infancy side effect. So this study compare efficacy of diclofenac and&#xD;
      bupivacaine by measured the pain score and requirement of morphine injection.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">December 30, 2017</completion_date>
  <primary_completion_date type="Actual">June 30, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compared pain score change from baseline at 2, 6 and 24 hours at post-operation between 2 groups by visual analogue scale</measure>
    <time_frame>2, 6 and 24 hours post-operation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Compared rescued dose of morphine injection</measure>
    <time_frame>Within 24 hours post-operation</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Cesarean Delivery</condition>
  <arm_group>
    <arm_group_label>Group Bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.5% bupivacaine 20ml divided in two; 10 ml intraperitoneal infiltration and 10 ml subcutaneous infiltration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Diclofenac</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>diclofenac 75 mg intramuscular, 2 hours postoperation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>0.5% bupivacaine 20ml divided in two; 10 ml intraperitoneal infiltration and 10 ml subcutaneous infiltration</description>
    <arm_group_label>Group Bupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac</intervention_name>
    <description>diclofenac 75 mg intramuscular, 2 hours postoperation</description>
    <arm_group_label>Group Diclofenac</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergo elective or urgency cesarean delivery at Rajavithi Hospital in&#xD;
             2016-2017&#xD;
&#xD;
               -  Urgency conditions: CPD, fail induction of labor, antepartum hemorrhage without&#xD;
                  hypovolemic shock, dystocia, previous cesarean section and active labor,&#xD;
                  malpresentation in labor, macrosomic presentation in labor&#xD;
&#xD;
          -  Pregnant women more than 20 years of age&#xD;
&#xD;
          -  Gestational age more than 37 week&#xD;
&#xD;
          -  Cesarean section under regional or general anesthesia&#xD;
&#xD;
          -  Ability to communicating, writing and reading Thai language&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to communicating or writing or reading Thai language&#xD;
&#xD;
          -  Contraindicated to bupivacaine or diclofenac or morphine&#xD;
&#xD;
          -  Pregnant women with emergency conditions&#xD;
&#xD;
          -  Have one or more complication of pregnancy&#xD;
&#xD;
          -  Intraoperative arrhythmia&#xD;
&#xD;
          -  Pregnant women less than 20 years of age&#xD;
&#xD;
          -  Regional anesthesia with morphine&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Natthida Mekwongtrakarn</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rajavithi Hospital</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>September 28, 2016</study_first_submitted>
  <study_first_submitted_qc>January 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2017</study_first_posted>
  <last_update_submitted>October 20, 2020</last_update_submitted>
  <last_update_submitted_qc>October 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

